HIV and fatty liver: a hidden risk revealed?

NCT ID NCT04795219

Ongoing Knowledge-focused Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how often fatty liver disease occurs in people living with HIV. Researchers will measure liver fat in 1,250 adults with HIV who are on stable treatment. The goal is to understand the true scale of this liver condition in this group, which has been largely overlooked in past research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV NAFLD NAFLD-HIV

Contacts and locations

Show contact details

Locations

Duke University

Durham, North Carolina, 27701, United States
Indiana University School of Medicine

Indianapolis, Indiana, 46202, United States
John Hopkins University

Baltimore, Maryland, 21287, United States
University of Alabama

Tuscaloosa, Alabama, 35487, United States
University of California, San Diego

La Jolla, California, 92037, United States
University of California, San Francisco

San Francisco, California, 94143, United States
University of Texas

Houston, Texas, 77030, United States
Virginia Commonwealth University

Richmond, Virginia, 23284, United States